Michael Yang, MD

Publications

• He T, Wildey G, McColl K, Savadelis A, Spainhower K, McColl C, Kresak A, Tan AC, Yang M, Abbas A, Dowlati A. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer. Mol Oncol. 2020 Oct 20. [Epub ahead of print] PubMed PMID: 33084222
• Lu C, Bera K, Wang X, Prasanna P, Xu J, Janowczyk A, Beig N, Yang M, Fu P, Lewis J, Choi H, Schmid RA, Berezowska S, Schalper K, Rimm D, Velcheti V, Madabhushi A. A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study. Lancet Digit Health. 2020 Nov;2(11):e594-e606. PubMed PMID: 33163952
• He T, Wildey G, McColl K, Savadelis A, Spainhower K, McColl C, Kresak A, Tan AC, Yang M, Abbas A, Dowlati A. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer. Mol Oncol. 2021 Jan;15(1):195-209. PubMed PMID: 33084222
• Alilou M, Prasanna P, Bera K, Gupta A, Rajiah P, Yang M, Jacono F, Velcheti V, Gilkeson R, Linden P, Madabhushi A. A Novel Nodule Edge Sharpness Radiomic Biomarker Improves Performance of Lung-RADS for Distinguishing Adenocarcinomas from Granulomas on Non-Contrast CT Scans. Cancers (Basel). 2021 Jun 3;13(11). PubMed PMID: 34205005
• Wang X, Bera K, Barrera C, Zhou Y, Lu C, Vaidya P, Fu P, Yang M, Schmid RA, Berezowska S, Choi H, Velcheti V, Madabhushi A. A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer. EBioMedicine. 2021 Jul;69:103481. PubMed PMID: 34265509
• Wildey G, Shay AM, McColl KS, Yoon S, Shatat MA, Perwez A, Spainhower KB, Kresak AM, Lipka M, Yang M, Behtaj M, Fu P, Alahmadi A, Mneimneh W, Abbas A, Dowlati A. Retinoblastoma expression and targeting by CDK4/6 inhibitors in small cell lung cancer. Mol Cancer Ther. 2022 Nov 18. [Epub ahead of print] PubMed PMID: 36399634
• Wang X, Barrera C, Bera K, Viswanathan VS, Azarianpour-Esfahani S, Koyuncu C, Velu P, Feldman MD, Yang M, Fu P, Schalper KA, Mahdi H, Lu C, Velcheti V, Madabhushi A. Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors. Sci Adv. 2022 Jun 3;8(22):eabn3966. PubMed PMID: 35648850
• Kleczko EK, Hinz TK, Nguyen TT, Gurule NJ, Navarro A, Le AT, Johnson AM, Kwak J, Polhac DI, Clambey ET, Weiser-Evans M, Merrick DT, Yang MC, Patil T, Schenk EL, Heasley LE, Nemenoff RA. Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity. NPJ Precis Oncol. 2023 Feb 4;7(1):15. PubMed PMID: 36739466
• Do M, Pokala SK, Attwell A, Yang MC. A Rare Cause of Abdominal Pain. Gastroenterology. 2023 Jun 29. [Epub ahead of print] PubMed PMID: 37393025
• Horn KJ, Fulte S, Yang M, Lorenz BP, Clark SE. Neutrophil responsiveness to IL-10 impairs clearance of Streptococcus pneumoniae from the lungs. J Leukoc Biol. 2023 Jun 29. [Epub ahead of print] PubMed PMID: 37381945

Practice Locations

UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

Specialty Information

Specialties

• Pathology, Board Certification